The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acq - P2P | Acquired



About Thoratec

Thoratec specializes in therapies to address advanced-stage heart failure. The company's products include the HeartMate II and HeartMate III LVAS (Left Ventricular Assist Systems) and Thoratec VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag and PediMag/PediVAS product lines. Thoratec is headquartered in Pleasanton, California.

Thoratec Headquarter Location

6035 Stoneridge Drive

Pleasanton, California, 94588,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Thoratec

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Thoratec is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,383 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Thoratec Patents

Thoratec has filed 234 patents.

The 3 most popular patent topics include:

  • Cardiology
  • Energy development
  • Fluid dynamics
patents chart

Application Date

Grant Date


Related Topics




Fluid dynamics, Pumps, Cardiovascular physiology, Cardiac anatomy, Cardiology


Application Date


Grant Date



Related Topics

Fluid dynamics, Pumps, Cardiovascular physiology, Cardiac anatomy, Cardiology



Latest Thoratec News

Artificial Heart Market by Emerging Technologies, Development Status and Market Dynamics with Key Players: Thoratec, SynCardia Systems, Cirtec, BiVACOR, MyLVAD, CARMAT, Jarvik Heart, Inc., Abbott, AbioMed, Cleveland Heart, CryoLife, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation

Jan 18, 2022

Search jobs 18-Jan-2022 Artificial Heart Market by Emerging Technologies, Development Status and Market Dynamics with Key Players: Thoratec, SynCardia Systems, Cirtec, BiVACOR, MyLVAD, CARMAT, Jarvik Heart, Inc., Abbott, AbioMed, Cleveland Heart, CryoLife, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation Artificial Heart Market research report are based upon SWOT analysis on which businesses can rely confidently. With the precise and high-tech information about healthcare industry, businesses can know about the types of consumers, consumer’s demands and preferences, their perspectives about the product, their buying intentions, their response to particular product, and their varying tastes about the specific product already existing in the market through this report. This information and market insights covered in the superior Artificial Heart market document assists with maximizing or minimizing the production of goods depending on the conditions of demand. Strategically analyzed facts and figures of the market and keen business insights covered in the credible Artificial Heart business document would be a major aspect in achieving enduring business growth. The report offers steadfast knowledge and information of revolutionizing market landscape, what already exists in the market, future trends or what the market expects, the competitive environment, and strategies to plan to outshine the competitors. This worldwide Artificial Heart market research report finds out the general market conditions, trends, inclinations, key players, opportunities, geographical analysis and many other parameters that helps drive business into the right direction. Download Sample of this Report to understand structure of the complete report (Including Full TOC, Table & Figures) @ Key Market Players mentioned in this report: Thoratec By Types: Bioanalytical Testing Services, Physical Characterization Services, Method Development, and Validation Services, Raw Material Testing Services, Batch-Release Testing Services, Stability Testing, Microbial Testing Services, Environmental Monitoring Services By Application: Market Analysis and Insights: Global Artificial Heart Market The artificial heart market is expected to witness market growth at a rate of 15.78% in the forecast period of 2022 to 2029 and is expected to reach USD 3876.89 million by 2029. Data Bridge Market Research report on artificial heart market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the incidence of cardiovascular disorders is escalating the growth of artificial heart market. Browse Full Report Along With Facts and Figures @ Global Artificial Heart Market Scope and Market Size The artificial heart market is segmented on the basis of type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. On the basis of type, the artificial heart market is segmented into Heart-Lung Machine and Mechanical Heart. Mechanical heart is further sub segmented into total artificial hearts and ventricular assist devices (VADs). On the basis of end user, the artificial heart market is segmented into hospitals and clinics, specialty centers and others. Artificial Heart Market, By Region: The artificial heart market is analyzed, and market size insights and trends are provided by country, type, and end user as referenced above. The countries covered in the artificial heart market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. Table of Contents: Global Artificial Heart Market 1 Introduction The research provides answers to the following key questions: What is the estimated growth rate of the market for the forecast period 2022–2029? What will be the market size during the estimated period? What are the key driving forces responsible for shaping the fate of the Energy Harvesting System market during the forecast period? Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Energy Harvesting System market? What are the prominent market trends influencing the development of the Energy Harvesting System market across different regions? What are the major threats and challenges likely to act as a barrier in the growth of the Energy Harvesting System market? What are the major opportunities the market leaders can rely on to gain success and profitability? The key questions answered in Artificial Heart Market report are: What are the market opportunities, market risks, and market overviews of the Artificial Heart Market? Who are the distributors, traders, and merchants in the Artificial Heart Market? What is the analysis of sales, income, and prices of the leading manufacturers in the Artificial Heart Market? What are the Artificial Heart market opportunities and threats faced by the global Artificial Heart Market vendors? What are the main factors driving the worldwide Artificial Heart Industry? What are the Top Players in Artificial Heart industry? What is the analysis of sales, income, and prices by type, application of the Artificial Heart market? What is regional sales, income, and price analysis for Artificial Heart Market? Inquire Before Buying This Research Report@ About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate. Contact Us: UK: +44 208 089 1725 Hong Kong: +852 8192 7475

  • When was Thoratec founded?

    Thoratec was founded in 1905.

  • Where is Thoratec's headquarters?

    Thoratec's headquarters is located at 6035 Stoneridge Drive, Pleasanton.

  • What is Thoratec's latest funding round?

    Thoratec's latest funding round is Acq - P2P.

  • Who are the investors of Thoratec?

    Investors of Thoratec include Advanced Technology Ventures, ARCH Venture Partners, OrbiMed Advisors and Venrock.

  • Who are Thoratec's competitors?

    Competitors of Thoratec include Abiomed.

You May Also Like


BiVACOR is a total artificial heart designed to take over the complete function of a patient's failing heart. The company's world headquarters is located in Houston, Texas, USA, and its international office is in Brisbane, Australia.

Jarvik Heart

Jarvik Heart is a private company that develops miniaturized heart assist devices for the treatment of severe heart failure.

Teleflex Medical

Teleflex Medical, fka Hudson Respiratory Care, manufactures and markets surgical instruments and devices in the United States and internationally. It offers surgical instruments and devices, cardiac devices, and other specialty products.


ReliantHeart is a provider in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the HeartAssist5, a next generation ventricular assist device (VAD) which has CE Mark approval for commercial sale in Europe. The HeartAssist5 is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world's only remotely monitored VAD.

Stryker Logo

Stryker (NYSE: SYK) is a medical technology company that offers a diverse array of products and services in Orthopedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

SynCardia Systems

SynCardia Systems is a manufacturer of the Total Artificial Heart. The SynCardia Total Artificial Heart is approved as a bridge to transplant for people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure). Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers.On September 30th, 2021, SynCardia Systems was acquired by Picard Medical. The terms of the transaction were not disclosed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.